On 3 June, the French Government published a Neurodegenerative Diseases Roadmap 2021-2022, outlining next steps which will be taken across different fields. Following the completion and evaluation of the French Neurodegenerative Disease Plan 2014-2019, France Alzheimer worked with other civil society organisations in France to engage with the French Government, emphasising the need for continued prioritisation of neurodegenerative diseases across different areas of health policy. In the response, the French Ministry of Health committed to publishing a shorter “Roadmap” identifying focused policy measures for continued work. A total of 18 actions are identified in the Roadmap, around the following 10 axes:
· Consolidation of achievements in terms of entry into the pathways
· Better response in situations of disruption of care due to psycho-behavioral disorders
· Pathways and responses adapted to young patients
· Better access to research
· Adaptation of hospital care (avoidance of inappropriate hospitalisations with upstream work and creation of resources for adapted hospital care)
· Adaptation of the Parkinson's patient's pathway (in particular neuro-stimulation)
· Promoting French efforts in Europe and exchanging best practices
· Prevention
· Medical and social care
· Democracy in health.
Within the report, the government commits to continued participation of France in the European Group of Governmental Experts on Dementia, as well as citing Alzheimer Europe’s 2019 prevalence estimates for the number of people living with dementia in France. The Roadmap can be downloaded (in French) at: https://solidarites-sante.gouv.fr/IMG/pdf/plan_pmnd_version_longue.pdf
